1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Advanced Wound Management Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 11
3 Advanced Wound Management Market, United States 15
3.1 Advanced Wound Management Market, United States, Revenue ($m), 2015-2025 15
3.1.1 Alginates Market, United States, Revenue ($m), by Segment, 2015-2025 18
3.1.2 Collagens Market, United States, Revenue ($m), by Segment, 2015-2025 20
3.1.3 Foams Market, United States, Revenue ($m), by Segment, 2015-2025 22
3.1.4 Hydrocolloids Market, United States, Revenue ($m), by Segment, 2015-2025 24
3.1.5 Hydrofibres Market, United States, Revenue ($m), by Segment, 2015-2025 26
3.1.6 Hydrogels Market, United States, Revenue ($m), by Segment, 2015-2025 28
3.1.7 Semi-Permeable Films Market, United States, Revenue ($m), by Segment, 2015-2025 30
3.1.8 Superabsorbents Market, United States, Revenue ($m), by Segment, 2015-2025 32
3.1.9 Wound Contact Layers Market, United States, Revenue ($m), by Segment, 2015-2025 34
3.2 Advanced Wound Management Market, United States, Volume (Units), 2015-2025 36
3.2.1 Alginates Market, United States, Volume (Units), by Segment, 2015-2025 39
3.2.2 Collagens Market, United States, Volume (Units), by Segment, 2015-2025 41
3.2.3 Foams Market, United States, Volume (Units), by Segment, 2015-2025 43
3.2.4 Hydrocolloids Market, United States, Volume (Units), by Segment, 2015-2025 45
3.2.5 Hydrofibres Market, United States, Volume (Units), by Segment, 2015-2025 47
3.2.6 Hydrogels Market, United States, Volume (Units), by Segment, 2015-2025 49
3.2.7 Semi-Permeable Films Market, United States, Volume (Units), by Segment, 2015-2025 51
3.2.8 Superabsorbents Market, United States, Volume (Units), by Segment, 2015-2025 53
3.2.9 Wound Contact Layers Market, United States, Volume (Units), by Segment, 2015-2025 55
3.3 Advanced Wound Management Market, United States, Average Price ($) , 2015-2025 57
3.4 Advanced Wound Management Market, United States, Distribution Share by Revenue ($m), 2019 61
3.5 Advanced Wound Management Market, United States, Company Share by Revenue ($m), 2019 62
4 Overview of Key Companies in United States, Advanced Wound Management Market 64
4.1 Smith & Nephew Plc 64
4.1.1 Company Overview 64
4.2 Molnlycke Health Care AB 64
4.2.1 Company Overview 64
4.3 ConvaTec Group Plc 64
4.3.1 Company Overview 64
4.4 3M Co 65
4.4.1 Company Overview 65
4.5 Coloplast A/S 65
4.5.1 Company Overview 65
4.6 BSN medical GmbH 65
4.6.1 Company Overview 65
4.7 Acelity Holdings, Inc. (Inactive) 65
4.7.1 Company Overview 65
4.8 Lohmann & Rauscher GmbH & Co. KG 66
4.8.1 Company Overview 66
4.9 B. Braun Melsungen AG 66
4.9.1 Company Overview 66
5 Advanced Wound Management Market Pipeline Products 67
6 Financial Deals Landscape 69
6.1 Acquisition 69
6.1.1 Stedical Scientific Acquires PermeaDerm 69
6.2 Debt Offerings 70
6.2.1 Integra LifeSciences Prices Private Placement of
0.5% Convertible Senior Notes Due 2025 for USD500 Million 70
6.3 Equity Offerings 72
6.3.1 NovaBay Pharma to Raise USD4.3 Million in Public Offering of Shares 72
6.3.2 Tenax Therapeutics Prices Private Placement of Shares and Warrants for USD2.8 Million 74
6.3.3 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 75
6.3.4 Synedgen Raises USD2.6 Million in Financing 76
6.3.5 Misonix Prices Public Offering of Shares for USD30 Million 77
6.3.6 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 79
6.3.7 Beyond Air Raises USD9.5 Million in Public Offering of Shares 81
6.3.8 Beyond Air Raises USD2 Million in Private Placement of Shares 83
6.3.9 Sonoma Pharma Raises USD1.6 Million in Public Offering of Shares 84
6.3.10 Avita Medical Raises USD15.4 Million in Private Placement of Shares 85
6.3.11 NovaBay Pharma Raises USD4.2 Million in Registered Direct Offering of Shares 86
6.3.12 NovaBay Pharma Raises USD2.7 Million in Private Placement of Preferred Stock and Warrants 88
6.3.13 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock 90
6.3.14 NovaBay Pharma Raises USD2.4 Million in Private Placement of Units 91
6.4 Partnerships 92
6.4.1 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 92
6.4.2 Mayo Clinic and W. L. Gore & Associates Form Joint Venture 93
6.4.3 Rochal Industries Enters into Licensing Agreement with Sanara MedTech 94
6.5 Private Equity 95
6.5.1 Audax Private Equity to Acquire Aspen Surgical Products from Hill-Rom for USD170 Million 95
6.6 Venture Financing 97
6.6.1 Poly Group Raises USD0.1 Million in Venture Financing 97
6.6.2 Akeso Biomedical Raises USD0.6 Million in Venture Financing 98
6.6.3 Turn Therapeutics Raises Funds through Series B Financing 99
6.6.4 Recovery Force Health Raises USD10 Million in Venture Financing 100
6.6.5 Electrochemical Oxygen Concepts Raises USD2.3 Million in Venture Financing 101
6.6.6 Omeza Secures Additional USD1.25 Million in Venture Funding 102
7 Recent Developments 103
7.1 Corporate Communications 103
7.1.1 Feb 21, 2020: Tenax announces the addition of Mayo Clinic expert, Dr. Barry Borlaug, to Scientific Advisory Board 103
7.1.2 Feb 14, 2020: CollPlant Biotechnologies raising $4.45 million in U.S. Private Placement 103
7.1.3 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 104
7.1.4 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 104
7.1.5 Jan 28, 2020: 3M Company: Departure of directors or certain officers 105
7.1.6 Jan 08, 2020: Midatech Pharma: Positive results from MTD201-102 study support subcutaneous route for long-acting octreotide product 105
7.1.7 Jan 08, 2020: Anavex Life Sciences issued new U.S. patent for ANAVEX2-73 treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis 107
7.1.8 Dec 19, 2019: World-Renowned Neurosurgeon selected to lead nationally-recognized Henry Ford Medical Group 107
7.1.9 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical 108
7.1.10 Dec 05, 2019: Johnson & Johnson names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors 109
7.1.11 Nov 27, 2019: Luna Innovations names Gene Nestro as Chief Financial Officer 109
7.1.12 Nov 26, 2019: Dr. Emanual Maverakis, recipient of presidential award for scientists and engineers, joins RenovaCare 110
7.1.13 Nov 18, 2019: RenovaCare appoints Alan L. Rubino as President and CEO 111
7.1.14 Oct 14, 2019: Anika appoints Mira Leiwant as vice president of regulatory affairs, quality, and clinical affairs 112
7.1.15 Oct 07, 2019: Xtant Medical names Sean Browne President and Chief Executive Officer 113
7.1.16 Oct 01, 2019: Sonoma Pharmaceuticals announces Management Changes 113
7.1.17 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 114
7.1.18 Sep 24, 2019: Dr. Frank Gerberick, Procter & Gamble product safety veteran, joins RenovaCare 114
7.1.19 Sep 16, 2019: NovaBay Pharmaceuticals names Finance Executive Jeff Zheng to its Board of Directors 115
7.1.20 Sep 13, 2019: FDA clears GE’s AI algorithms to identify pneumothorax 115
7.1.21 Sep 06, 2019: Cytokinetics to present on its Hypertrophic Cardiomyopathy drug candidate CK-274 at 23rd Annual HFSA Scientific Meeting 116
7.1.22 Sep 05, 2019: Mary Beth Vitale appointed to Luna Innovations board of directors 117
7.1.23 Aug 26, 2019: GT Medical Technologies to be honored with an AZBio Fast Lane Award 118
7.1.24 Aug 20, 2019: Dr. Robin Robinson, founding director of BARDA joins RenovaCare 119
7.1.25 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 121
7.1.26 Jul 22, 2019: Adynxx adds Gregory J. Flesher to board of directors, completes up-listing to OTCQB market 121
7.1.27 Jul 08, 2019: Anika appoints James Loerop as executive vice president of business development and strategic planning 122
7.1.28 Jul 01, 2019: Medline mourns passing of co-founder Jim Mills 122
7.1.29 Jun 24, 2019: Integra LifeSciences announces promotion of Glenn Coleman to newly-created role of chief operating officer and appointment of Carrie Anderson as chief financial officer 123
7.1.30 Jun 20, 2019: ACell receives supplier legacy award from Premier 124
7.1.31 Jun 17, 2019: NovaBay Pharmaceuticals appoints Justin Hall President and CEO, and Jason Raleigh CFO 124
7.1.32 Jun 17, 2019: Joerns adds Vice President of Human Resources to support company's growth 125
7.2 Financial Announcements 125
7.2.1 Mar 03, 2020: GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ) Phase III trials at the 46th annual meeting of NANOS 125
7.2.2 Feb 19, 2020: Integra LifeSciences reports fourth quarter and full-year 2019 financial results and provides 2020 financial guidance 127
7.2.3 Feb 14, 2020: Sonoma Pharmaceuticals reports third quarter FY 2020 financial results 128
7.2.4 Jan 29, 2020: Avery Dennison announces fourth quarter and full year 2019 results 129
7.2.5 Jan 22, 2020: Johnson & Johnson reports 2019 fourth-quarter and full year results 131
7.2.6 Jan 17, 2020: Scandinavian ChemoTech receives its first order from their new distributor in India 131
7.2.7 Jan 15, 2020: SomaLogic adds three new SomaSignal tests to its current offerings 133
7.2.8 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 134
7.2.9 Dec 31, 2019: Belgium customers select C-RAD’s innovative SIGRT solution 134
7.2.10 Dec 18, 2019: Terason partners with AmCad BioMed to provide more efficient solutions to assess and diagnose obstructive sleep apnea 136
7.2.11 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 138
7.2.12 Nov 14, 2019: Sonoma Pharmaceuticals reports second quarter FY 2020 financial results 140
7.2.13 Nov 07, 2019: NovaBay Pharmaceuticals reports 2019 third quarter financial results 141
7.2.14 Nov 07, 2019: Xtant Medical announces third quarter 2019 financial results 142
7.2.15 Nov 05, 2019: Luna Innovations reports strong third-quarter 2019 results 143
7.2.16 Oct 24, 2019: Integra LifeSciences reports third quarter 2019 financial results 144
7.2.17 Oct 24, 2019: Anika reports third quarter 2019 financial results 145
7.2.18 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 146
7.2.19 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 147
7.2.20 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 148
7.2.21 Aug 13, 2019: Sonoma pharmaceuticals reports first quarter FY 2020 financial results 150
7.2.22 Aug 08, 2019: Xtant Medical announces second quarter 2019 financial results 150
7.2.23 Aug 07, 2019: NovaBay Pharmaceuticals reports 2019 second quarter financial results 151
7.2.24 Aug 01, 2019: KIYATEC Assay hits the mark in study to predict patient response to first line ovarian cancer drugs 152
7.2.25 Jul 24, 2019: Integra LifeSciences reports second quarter 2019 financial results 153
7.2.26 Jul 24, 2019: Anika reports second quarter 2019 financial results 154
7.2.27 Jul 22, 2019: Study investigates the ability of continuous noninvasive hemoglobin monitoring with Masimo SpHb to reflect acute hemodilution during incremental fluid administration 155
7.2.28 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 157
7.2.29 Jul 08, 2019: Sonoma Pharmaceuticals reports fiscal year and fourth quarter 2019 financial results 157
7.2.30 May 22, 2019: Portola Pharmaceuticals announces new analysis from the ANNEXA-4 study of its Factor Xa inhibitor reversal agent andexxa in patients with spontaneous (Non-Traumatic) intracranial hemorrhage 158
7.2.31 May 21, 2019: Sanuwave Health reports first quarter 2019 financial results 160
7.2.32 May 15, 2019: Xtant Medical announces first quarter 2019 financial results 162
7.3 Legal And Regulatory 163
7.3.1 Dec 03, 2019: Ferris Mfg. Corp. is pleased to announce settlement with an unauthorized distributor of its medical products 163
7.3.2 Jun 20, 2019: SEC investigation of Misonix ends with no action 163
7.4 Other Significant Developments 163
7.4.1 Apr 16, 2020: GEMCORE adapts wound dressing to help protect healthcare workers from friction injuries caused by personal protective equipment and donates 8,000 units 163
7.4.2 Apr 08, 2020: Anika takes actions to strengthen liquidity in light of covid-19 164
7.4.3 Mar 31, 2020: Aroa Biosurgery opens new pathway for advanced wound treatment amidst covid-19 disruption in the United States 165
7.4.4 Jan 23, 2020: Johnson & Johnson announces $250 million commitment to support Frontline Health Workers, reaching 100 million people by 2030 165
7.4.5 Jan 13, 2020: Healthpeak announces lease with Johnson & Johnson Subsidiary at The Shore at Sierra Point 166
7.4.6 Oct 29, 2019: Dissolution of a wholly-owned subsidiary–Clearbridge Health USA 166
7.4.7 Aug 21, 2019: Joerns Healthcare completes reorganization plans 166
7.4.8 Jul 29, 2019: NovaBay Pharmaceuticals reports 2019 second quarter net sales of $1.8 million 167
7.4.9 Jul 26, 2019: Court confirms reorganization plan for Joerns Healthcare 167
7.4.10 Jun 18, 2019: Pathway Health announces distribution agreement with Briggs Healthcare 168
7.4.11 May 24, 2019: NanoVibronix provides business update for the first quarter of 2019 168
7.4.12 May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review 169
7.5 Product News 170
7.5.1 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 170
7.5.2 Oct 04, 2019: MEI Pharma announces updated clinical data from ME-401 phase 1b study in patients with Indolent B-cell Malignancies 170
7.6 Strategy And Business Planning 171
7.6.1 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 171
7.6.2 Dec 13, 2019: 3M to divest drug delivery business to Altaris Capital in $650m deal 172
7.6.3 Aug 01, 2019: SeaSpine announces the launch of the Shoreline RT Cervical Interbody Implant System, featuring Reef Topography 173
7.6.4 Jun 18, 2019: Study presented at American Diabetes Association 79th Scientific Sessions observed substantially less hypoglycemia with use of Glytec’s Technology 174
8 Appendix 175
8.1 Research Methodology 176
8.1.1 Coverage 176
8.1.2 Secondary Research 176
8.1.3 Primary Research 177
8.1.4 Market Modeling and Forecasting 178
8.1.5 Company Share Analysis 179
8.1.6 Distribution Share Analysis 180
8.1.7 Benchmarking 180
8.2 GlobalData Consulting 181
8.3 Contact Us 181
8.4 Disclaimer 181
